133 related articles for article (PubMed ID: 8584664)
1. Trace amines in hepatic encephalopathy.
Mousseau DD; Butterworth RF
Prog Brain Res; 1995; 106():277-84. PubMed ID: 8584664
[TBL] [Abstract][Full Text] [Related]
2. False neurotransmitters and hepatic coma.
Fischer JE
Res Publ Assoc Res Nerv Ment Dis; 1974; 53():53-73. PubMed ID: 4612663
[No Abstract] [Full Text] [Related]
3. The brain octopamine and phenylethanolamine content in rats in thioacetamide-induced hepatogenic encephalopathy.
Hilgier W; Zitting A; Albrecht J
Acta Neurol Scand; 1985 Mar; 71(3):195-8. PubMed ID: 3922198
[TBL] [Abstract][Full Text] [Related]
4. Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors.
Frascarelli S; Ghelardoni S; Chiellini G; Vargiu R; Ronca-Testoni S; Scanlan TS; Grandy DK; Zucchi R
Eur J Pharmacol; 2008 Jun; 587(1-3):231-6. PubMed ID: 18486124
[TBL] [Abstract][Full Text] [Related]
5. Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma.
Smith AR; Rossi-Fanelli F; Ziparo V; James JH; Perelle BA; Fischer JE
Ann Surg; 1978 Mar; 187(3):343-50. PubMed ID: 637594
[TBL] [Abstract][Full Text] [Related]
6. [Changes in and modulation of receptor activity in hepatic encephalopathy].
Kienzl E; Riederer P; Brücke T; Kleinberger G; Jellinger K
Infusionsther Klin Ernahr; 1985 Feb; 12(1):32, 37-45. PubMed ID: 2859245
[TBL] [Abstract][Full Text] [Related]
7. CNS tryptamine metabolism in hepatic coma.
Young SN; Lal S
J Neural Transm; 1980; 47(3):153-61. PubMed ID: 7381453
[TBL] [Abstract][Full Text] [Related]
8. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome.
Albrecht J; Jones EA
J Neurol Sci; 1999 Nov; 170(2):138-46. PubMed ID: 10617392
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis of hepatic encephalopathy (author's transl)].
Holm E; Striebel JP; Münzenmaier R; Kattermann R
Leber Magen Darm; 1977 Aug; 7(4):241-54. PubMed ID: 19666
[TBL] [Abstract][Full Text] [Related]
10. Effects of dietary amino acids on brain amino acids and transmitter amines in rats with a portacaval shunt.
Kamata S; Okada A; Watanabe T; Kawashima Y; Wada H
J Neurochem; 1980 Nov; 35(5):1190-9. PubMed ID: 6161235
[TBL] [Abstract][Full Text] [Related]
11. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.
Xie Z; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):617-28. PubMed ID: 18182557
[TBL] [Abstract][Full Text] [Related]
12. Changes in brain catecholamine levels in human cirrhotic hepatic encephalopathy.
Cuilleret G; Pomier-Layrargues G; Pons F; Cadilhac J; Michel H
Gut; 1980 Jul; 21(7):565-9. PubMed ID: 6776015
[TBL] [Abstract][Full Text] [Related]
13. Substitute and alternative neurotransmitters in neuropsychiatric illness.
Baldessarini RJ; Fischer JE
Arch Gen Psychiatry; 1977 Aug; 34(8):958-64. PubMed ID: 19004
[TBL] [Abstract][Full Text] [Related]
14. [Study of the ameliorating effects of an enteral nutrient for liver failure on hepatic encephalopathy: effects of SF-1008C on plasma and brain free amino acids, intracerebral amine concentrations and electroencephalogram in portacaval shunted rats with ammonia loading].
Kido Y; Sugiyama K; Nakao S; Kashiyama E; Suda T; Miyamoto G; Shimizu T; Shintani S; Kohri H
Nihon Yakurigaku Zasshi; 1986 Jul; 88(1):47-56. PubMed ID: 3093339
[TBL] [Abstract][Full Text] [Related]
15. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.
Bunzow JR; Sonders MS; Arttamangkul S; Harrison LM; Zhang G; Quigley DI; Darland T; Suchland KL; Pasumamula S; Kennedy JL; Olson SB; Magenis RE; Amara SG; Grandy DK
Mol Pharmacol; 2001 Dec; 60(6):1181-8. PubMed ID: 11723224
[TBL] [Abstract][Full Text] [Related]
16. Role of tryptophan in the elevated serotonin-turnover in hepatic encephalopathy.
Herneth AM; Steindl P; Ferenci P; Roth E; Hörtnagl H
J Neural Transm (Vienna); 1998; 105(8-9):975-86. PubMed ID: 9869330
[TBL] [Abstract][Full Text] [Related]
17. Region-selective decreases in densities of [3H]tryptamine binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.
Mousseau DD; Layrargues GP; Butterworth RF
J Neurochem; 1994 Feb; 62(2):621-5. PubMed ID: 8294925
[TBL] [Abstract][Full Text] [Related]
18. Excretion of amines and their metabolites by two patients in hepatic coma treated with L-dopa.
Tyce GM; Stockard J; Sharpless NS; Muenter MD
Clin Pharmacol Ther; 1983 Sep; 34(3):390-8. PubMed ID: 6883916
[TBL] [Abstract][Full Text] [Related]
19. Down regulation of striatal dopamine receptors in experimental hepatic encephalopathy.
Baraldi M; Zeneroli ML; Ricci P; Caselgrandi E; Ventura E
Life Sci; 1983 Mar; 32(13):1417-25. PubMed ID: 6403789
[TBL] [Abstract][Full Text] [Related]
20. The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain.
Burchett SA; Hicks TP
Prog Neurobiol; 2006 Aug; 79(5-6):223-46. PubMed ID: 16962229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
